Results 231 to 240 of about 40,261 (314)

Nominal plan robustness may predict plan degradation in proton therapy for oropharyngeal head‐and‐neck cancer

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Background Proton therapy for head‐and‐neck (HN) cancer offers superior organ‐at‐risk sparing compared to photon therapy, but is challenged by frequent anatomical changes during treatment. These changes need to be monitored with routine verification CTs (vCTs), which are used to trigger adaptive replans when deemed necessary by the clinical ...
Mark J. Zakhary   +9 more
wiley   +1 more source

A Core Head, Neck, and Neuroanatomy Syllabus for Physical Therapy Student Education

open access: yesClinical Anatomy, Volume 39, Issue 4, Page 436-460, May 2026.
ABSTRACT Head, neck, and neuroanatomy are essential components of physical therapy education due to their broad clinical applications. Detailed syllabi exist for medical students, yet none have been developed for physical therapy. This study aimed to produce an International Federation of Associations of Anatomists core head, neck, and neuroanatomy ...
Stephanie J. Woodley   +4 more
wiley   +1 more source

Determinants Associated With Pesticide Exposure in Patients With Head and Neck Cancer: Protocol for a Systematic Review.

open access: yesJMIR Res Protoc
Sánchez-Ramírez GA   +5 more
europepmc   +1 more source

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang   +19 more
wiley   +1 more source

The Clinical Benefits of Nutritional Supplementation Across the Chemotherapy Journey in Cancer Patients: A Multicenter Prospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Purpose This study aimed to explore the clinical benefits of receiving nutritional supplementation (NS) throughout the whole course of chemotherapy. Methods This multicenter prospective cohort study totally included 251 cancer patients requiring nutritional support and scheduled for chemotherapy.
Jia‐Xin Huang   +23 more
wiley   +1 more source

Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Ahmed Arabi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy